Archer Investment Corp »

Galectin Therapeutics shares owned by Archer Investment Corp

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Archer Investment Corp from 13F filings

Historical chart of Archer Investment Corp investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Archer Investment Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Archer Investment Corp

Quarter filed Position value Share count Share price at filing
2025-09-30 $47k 11k 4.24

More positions owned by Archer Investment Corp

First Trust Capital Etf Strength Etf (FTCS)
Invesco Qqq Tr Unit Ser 1 Etf (QQQ)
Spdr Portfolio S&p 500 Etf Etf (SPLG)
Invesco Exchange Traded Fd Tr S&p500 Eql Wgt Etf (RSP)
First Tr Viii Vest Etf U S Equity Moderate Buffer July Etf (GJUL)
Innovator Etfs Trust Equity Defined Protection Etf - 1 Yr Aug Etf (ZAUG)
First Tr Exch Trd Alphdx Fd Ii India Nfty50 Eqw Etf (NFTY)
Apple (AAPL)
Microsoft Corporation (MSFT)
J P Morgan Exchange Traded Fd Equity Premium Etf (JEPI)
Innovator Etfs Trust Us Eqt Ultra Bf Etf (UAUG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Prologis Reit (PLD)
JPMorgan Chase & Co. (JPM)

View all positions for Archer Investment Corp

Top funds holding Galectin Therapeutics

Vanguard Group
Advisor Group Holdings
BlackRock
Geode Capital Management
Susquehanna International
Marshall Wace
Sontag Advisory
LPL Financial
Geneos Wealth Management
Commonwealth Equity Services
Vivaldi Capital Management
State Street Corporation
Morgan Stanley
Retirement Guys Formula
Sovran Advisors

View all funds holding Galectin Therapeutics